Mostrar el registro sencillo del ítem
dc.contributor.author
Fuertes, Mercedes Beatriz
dc.contributor.author
Kacha, Aalok K.
dc.contributor.author
Kline, Justin
dc.contributor.author
Woo, Seng Ryong
dc.contributor.author
Kranz, David M.
dc.contributor.author
Murphy, Kenneth M.
dc.contributor.author
Gajewski, Thomas F.
dc.date.available
2017-01-05T20:17:56Z
dc.date.issued
2011-09
dc.identifier.citation
Fuertes, Mercedes Beatriz; Kacha, Aalok K. ; Kline, Justin ; Woo, Seng Ryong ; Kranz, David M. ; et al.; Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells; Rockefeller Univ Press; Journal Of Experimental Medicine; 208; 10; 9-2011; 2005-2016
dc.identifier.issn
0022-1007
dc.identifier.uri
http://hdl.handle.net/11336/10886
dc.description.abstract
Despite lack of tumor control in many models, spontaneous T cell priming occurs frequently in response to a growing tumor. However, the innate immune mechanisms that promote natural antitumor T cell responses are undefined. In human metastatic melanoma, there was a correlation between a type I interferon (IFN) transcriptional profile and T cell markers in metastatic tumor tissue. In mice, IFN-b was produced by CD11c(+) cells after tumor implantation, and tumor-induced T cell priming was defective in mice lacking IFN-a/bR or Stat1. IFN signaling was required in the hematopoietic compartment at the level of host antigen-presenting cells, and selectively for intratumoral accumulation of CD8a(+) dendritic cells, which were demonstrated to be essential using Batf3(-/-) mice. Thus, host type I IFNs are critical for the innate immune recognition of a growing tumor through signaling on CD8alfa(+) DCs.
dc.format
application/pdf
dc.language.iso
eng
dc.publisher
Rockefeller Univ Press
dc.rights
info:eu-repo/semantics/openAccess
dc.rights.uri
https://creativecommons.org/licenses/by-nc-sa/2.5/ar/
dc.subject
Interferon
dc.subject
Tumor
dc.subject
Cd8 T Cell
dc.subject
Dendritic Cell
dc.subject.classification
Inmunología
dc.subject.classification
Medicina Básica
dc.subject.classification
CIENCIAS MÉDICAS Y DE LA SALUD
dc.title
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8alpha+ dendritic cells
dc.type
info:eu-repo/semantics/article
dc.type
info:ar-repo/semantics/artículo
dc.type
info:eu-repo/semantics/publishedVersion
dc.date.updated
2016-12-30T13:42:57Z
dc.identifier.eissn
1540-9538
dc.journal.volume
208
dc.journal.number
10
dc.journal.pagination
2005-2016
dc.journal.pais
Estados Unidos
dc.journal.ciudad
Birmingham, Alabama
dc.description.fil
Fil: Fuertes, Mercedes Beatriz. Consejo Nacional de Investigaciones Científicas y Técnicas; Argentina. University Of Chicago; Estados Unidos
dc.description.fil
Fil: Kacha, Aalok K. . University Of Chicago; Estados Unidos
dc.description.fil
Fil: Kline, Justin . University Of Chicago; Estados Unidos
dc.description.fil
Fil: Woo, Seng Ryong . University Of Chicago; Estados Unidos
dc.description.fil
Fil: Kranz, David M. . University Of Illinois; Estados Unidos
dc.description.fil
Fil: Murphy, Kenneth M. . Washington University in St. Louis; Estados Unidos
dc.description.fil
Fil: Gajewski, Thomas F. . University Of Chicago; Estados Unidos
dc.journal.title
Journal Of Experimental Medicine
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/url/http://jem.rupress.org/content/208/10/2005
dc.relation.alternativeid
info:eu-repo/semantics/altIdentifier/doi/http:/dx.doi.org/10.1084/jem.20101159
Archivos asociados